Pfizer files for clearance to use booster dose on children aged 5 to 11

US pharmaceutical company Pfizer has filed a request before the US Food and Drug Administration (FDA) this week for an emergency clearance to vaccinate children aged 5 to 11 with a 10-microgram booster dose against the SARS-CoV-2 Omicron variant.